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Influence of premorbid BMI on clinical
characteristics at presentation of
adolescent girls with eating disorders
Ingemar Swenne
Abstract
Background: Considering the prevalence of obesity in society it can be expected that some adolescents with an
eating disorder (ED) start weight loss from an overweight and present at a near-normal weight. Presently, the
influence of premorbid BMI on clinical characteristics of adolescent girls presenting with an ED has ben studied.
Method: Premorbid growth charts were available for 275 postmenarcheal adolescent girls presenting with an ED
(anorexia nervosa = 27, (subthreshold) bulimia nervosa = 9, restrictive EDNOS = 239). Initial assessment included
measurement of weight and length, physical examination, blood sampling and administration of the Eating
Disorder Examination-Questionnaire youth version (EDE-Q).
Results: Despite greater weight loss girls with a high premorbid body mass index (BMI) had a higher BMI at
presentation compared to those with a lower premorbid BMI. Although not underweight some presented with
clinical and laboratory signs of starvation. These signs were related to not only low BMI but also to rapid and large
weight loss. Their EDE-Q scores did not differ from those of girls who presented with an underweight.
Conclusion: Girls with a restrictive ED and premorbid overweight may present with a near-normal BMI. They can
nevertheless be medically compromised and have eating disturbed cognitions at the level of underweight girls.
They should not be regarded as having a less severe ED but merit full assessment and a start of treatment.
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Background
With overweight and obesity prevalent in society it must
be expected that some adolescents falling ill with an eat-
ing disorder (ED) start weight loss from an overweight.
With overweight there may even be an increased risk of
developing an ED considering the relationship between
obesity, body dissatisfaction and restrictive eating [1–4].
Body dissatisfaction and the wish to be thinner may be
strong and attempts to diet, initially appraisable, may
take their own course and develop into an ED.
It is an old observation that patients with anorexia
nervosa (AN) often have a weight above average prior to
the onset of weight loss [5]. This has also been observed
in adolescents with restrictive ED not otherwise speci-
fied (EDNOS) for whom growth charts from the school
health services could be used to document premorbid
weight and height [6]. Adolescents with restrictive ED
who start their weight loss from an overweight may have
a long duration of ED symptoms but nevertheless
present with higher BMI than those with a premorbid
weight in the average range [7–10]. Despite considerable
weight loss they do not reach the weight criterion for
AN but fall into the EDNOS category. ED cognitions
may nevertheless be in parity with those of underweight
adolescents with ED [9–12]. Indeed, the difference
between premorbid and current weight, often termed
weight suppression [13], is an independent predictor
of ED psychopathology [14]. These patients may
present a considerable clinical challenge due to an
intense fear of a weight gain which would return
them to their previous overweight. If they maintain
their weight suppression this may adversely influence
outcome of the ED [14, 15]. Moreover, despite not
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being underweight they may have signs of medical
instability and require medical intervention at the
start of treatment [16, 17].
To further elucidate the relationship between premor-
bid BMI and clinical features at presentation of an ED
we have analysed a sample of adolescents with ED and
with objective measures of premorbid BMI available.
In doing so we have included only postmenarcheal
girls since those who have not completed puberty and
reached menarche before onset of the ED have a dif-
ferent growth pattern [18]. It was hypothesized that
adolescents who start weight loss at a higher BMI
would not be as underweight at presentation as those
with premorbid BMI closer to population average but
that they would differ little in eating disturbed cogni-
tions. It was also hypothesized that adolescents with
rapid weight loss would present with clinical and la-




The Child and Adolescent Eating Disorders Unit of
Uppsala University Hospital is a specialised service offer-
ing treatment to all patients with an ED and <18 years
of age in the county (population 335 882 of which 69
314 < 18 years on Dec 31 2010). Patients are initially
assessed by a paediatrician according to a structured
protocol including the history of the ED, demographic
and medical background data, a physical examination,
and blood sampling. Referral is usually by the school
health services or following a direct contact with the
hospital by the family. Patients are seen without delay,
usually within 2 weeks following receipt of referral. With
few exceptions the patients have not been treated for
their ED prior to the initial assessment. An eating dis-
order diagnosis is established and parents are informed
that start of treatment aims at stopping weight loss and
normalising eating by parents taking charge of meal
routines and advice is given on how to start this
[19]. A first follow-up is 1 week later at which diag-
nostic interviews are completed, self-report instru-
ments administered and a diagnosis according to the
Diagnostic and Statistical Manual of Mental Disor-
ders, 4th edition (DSM-IV) finalized. For the present
investigation patients were retrospectively reclassified
according to the criteria of DSM-5.
During the period August 2010–August 2015 355
adolescents were assessed for an ED. The present study is
an analysis of data from 288 postmenarcheal girls who
had not previously been treated for their ED. All partici-
pants and their guardians consented to participating in
the study. The protocol was approved by the Ethics com-
mittee of the Faculty of Medicine of Uppsala University.
Study measures and statistics
Growth charts were procured from the school health
services. A recorded premorbid maximal weight could
be obtained for 275/288 (95 %) of the postmenarcheal
girls and was a prerequisite for inclusion in the analyses.
It had been reached less than a year before presentation
for 185 (64 %). A prepubertal weight at approximately
age seven was available for 231 (80 %). A recorded
weight 5–63 days (24 ± 15 days; mean ± SD) prior to as-
sessment was available in 246 (85 %). A family doctor or
a nurse in the school health services had usually re-
corded this weight. Total weight loss was calculated as
the difference between maximal recorded weight on the
school growth charts and weight at assessment. Final
rate of weight loss was calculated for the weight loss
from the last recorded weight prior to assessment.
Body mass index (BMI) was calculated as weight/height2
(kg/m2). BMI was recalculated into BMI standard de-
viation scores (BMI SDS), which constitutes a meas-
ure of leanness corrected for age and height [20].
Timing of menarche was by patients/parents recall at
assessment and often corroborated by notes on the growth
charts. Gynaecological age was calculated as the difference
between age at assessment and age at menarche.
The self-report instruments Eating Disorders
Examination-Questionnaire youth version (EDE-Q) [21],
Montgomery-Åsberg Depression Rating Scale-Self report
(MADRS-S) [22, 23] were administered to assess eating
disturbed ideation and depressive symptoms, respectively.
Laboratory analyses of non-fasting blood samples were
performed at the Department of Clinical Chemistry at
the Uppsala University Hospital as part of the clinical
work-up of the patients. Blood samples had been obtained
for 268 (97 %) of the participants. The laboratory is certi-
fied by a Swedish government authority (Swedac). The
correlation and stability of the assays were continuously
reviewed. The total assay variation in the individual
hormone assays was less than 5 %.
Patients were grouped by their premorbid BMI SDS
into one SDS wide classes. Values are given as means ±
SD. Differences in outcome variables between BMI SDS
classes were compared using a one-sided ANOVA for
continuous data and Chi-square test for categorical data.
The relationship of BMI SDS and (rate of) weight loss
with clinical and laboratory measures was analysed by a
linear stepwise regression or by logistic regression. All
analyses were performed with SPSS 20.0.0.
Results
The majority of patients had a premorbid BMI SDS
above the population average (i.e., BMI SDS = 0). The
average premorbid BMI SDS for the whole group was
0,73 ± 1,00 (Fig. 1). The distribution of patients in the
five premorbid BMI SDS classes is shown in Table 1.
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The patient in the higher premorbid BMI SDS classes
had a higher BMI also at their prepubertal measure-
ments. Moreover, from prepuberty to their top weight
girls of the higher premorbid BMI SDS classes increased
in BMI SDS while the opposite was true for the lower
BMI SDS classes. The girls in the higher premorbid BMI
SDS classes reached menarche at an earlier age than
those in the lower BMI SDS classes.
At presentation of the ED age, gynaecological age and
duration of ED symptoms did not differ between the
premorbid BMI SDS classes. Those in the leanest pre-
morbid BMI SDS classes were also the leanest at assess-
ment. The patients in the higher premorbid BMI SDS
classes were not underweight despite having lost more
weight than those with lower premorbid BMI SDS. The
rate of weight loss immediately preceding presentation
did not differ between BMI SDS classes. Amenorrhea
was reported in all premorbid BMI SDS classes and
ranged from 37 to 51 % of the patients not on hormonal
anticonception in premorbid BMI SDS classes 1–4. In
the highest premorbid BMI SDS class only 13 % were
amenorrhoic. Exercise as a means to regulate weight was
common in all premorbid BMI SDS classes and about
one third of the patients admitted to vomiting.
EDE-Q global score, the EDE-Q restraint, shape con-
cern and weight concern subscale scores and the
MADRS-S score differed between premorbid BMI SDS
classes. For all these measures Tukey’s and Scheffe’s
post-hoc tests showed that premorbid BMI SDS classes
2–5 formed homogenous subsets so that only BMI SDS
class 1 differed from all the other classes.
A majority of 239 (85 %) patients had an EDNOS of a
restrictive subtype. AN was more frequent in the lower
premorbid SDS classes in which the girls presented with
a lower BMI SDS.
Clinical and laboratory parameters at presentation did
not differ between premorbid BMI SDS classes with the
exception of systolic blood pressure which was lower in
the lower premorbid BMI SDS classes. These parameters
were further analysed by entering them as dependent
variables against BMI SDS at presentation, weight loss
and rate of weight loss at presentation in a stepwise lin-
ear regression analysis (Table 2). Pulse rate, systolic
blood pressure and circulating hormones were all posi-
tively related to BMI SDS at presentation. There was
also in varying degrees an inverse relationship with the
magnitude of weight loss and the rate of ongoing weight
loss at presentation. For those not on hormonal contra-
ceptives (n = 234) secondary amenorrhea was entered as
the dependent variable in a logistic regression analysis
against BMI SDS, weight loss and rate at weight loss
at presentation as independent variables. BMI SDS
(odds ratio (OR) 2,49, confidence interval (CI) 1,77–3,51,
p < 0,001 for a one unit difference) and weight loss
(OR 3,09, CI 1,74–5,45, p < 0,001 for a 10 kg weight loss)
independently predicted amenorrhea.
Fig. 1 Body mass index (BMI) standard deviation score at the maximal premorbid weight of 275 postmenarcheal adolescent girls presenting with
an eating disorder. BMI SDS = 0 (solid line represents the population average. The average of the present sample (BMI SDS 0,73 ± 1,00; mean ± SD) is
indicated by the dotted line
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Discussion
The data confirm the hypothesis that adolescents with
restrictive ED and a high premorbid BMI are less lean at
presentation despite a greater weight loss [10]. The im-
portant notion is that they nevertheless can have ED
cognitions at the same level as more emaciated patients
and have signs and laboratory findings of starvation des-
pite near-normal weight. They may thus be as treatment
requiring as emaciated patients with AN [17].
Signs of starvation such a low blood pressure and low
heart rate are related to low weight [24]. As criteria for
medical instability they are used for decisions on medical
Table 1 Anthropometric measurements, selected clinical and laboratory variables, and self-report instruments in 275 postmenarcheal
adolescent girls presenting with an eating disorder
Premorbid BMI SDS class 1 2 3 4 5 p
N 11 60 100 79 25
Prepubertal age (years) 7,5 ± 0,7 7,3 ± 1,0 7,3 ± 1,0 7,2 ± 0,8 7,4 ± 0,6 NS
Prepubertal BMI SDS −0,73 ± 0,76 −0,12 ± 0,79 0,60 ± 0,85 1,31 ± 0,78 1,76 ± 0,82 <0,001
Age at menarche (years) 13,4 ± 1,12 12,7 ± 1,0 12,6 ± 1,0 12,3 ± 0,9 12,4 ± 0,8 p = 0,002
Age at documented top weight (year) 15,4 ± 1,4 14,7 ± 1,3 14,7 ± 1,3 14,3 ± 1,4 14,3 ± 1,7 NS
BMI SDS at documented top weight −1,58 ± 0,62 −0,28 ± 0,47 0,62 ± 0,44 1,43 ± 0,35 2,35 ± 0,43 <0,001
BMI SDS change from prepuberty to top weight −0,83 ± 0,64 −0,21 ± 0,78 0,01 ± 0,82 0,17 ± 0,76 0,68 ± 0,80 <0,001
Age at presentation (years) 15,8 ± 1,3 15,4 ± 1,4 15,6 ± 1,3 15,3 ± 1,4 15,7 ± 1,4 NS
Gynecological age (years) 2,2 ± 1,5 2,7 ± 1,4 3,0 ± 1,4 3,0 ± 1,3 3,3 ± 1,4 NS
Duration of eating disturbed symptoms (months) 9 ± 12 9 ± 9 10 ± 10 10 ± 9 12 ± 11 NS
BMI SDS at presentation −2,79 ± 0,98 −1,60 ± 0,72 −0,61 ± 0,93 −0,13 ± 1,01 0,46 ± 1,11 <0,001
Weight loss (kg) 4,5 ± 3,8 5,0 ± 4,2 5,7 ± 4,9 9,5 ± 5,7 14,3 ± 7,9 <0,001
Rate of weight loss immediately preceding presentation (g/day) 74 ± 68 44 ± 62 31 ± 61 52 ± 66 60 ± 69 NS
Menstrual status (menses/amenorrhea/hormonal anticonception) 6/4/1 26/27/7 52/30/18 38/28/13 20/3/2 NS
(55/36/9 %) (43/45/12 %) (52/30/18 %) (48/36/16 %) (80/12/8 %)
Exercise as part of weight controlling behaviour 8 (73 %) 44 (73 %) 73 (73 %) 62 (79 %) 19 (76 %) NS
Vomiting as part of weight controlling behaviour 1 (9 %) 16 (27 %) 33 (33 %) 20 (25 %) 7 (28 %) NS
EDE-Q global score 1,7 ± 1,7 2,6 ± 1,5 3,3 ± 1,7 3,2 ± 1,6 3,1 ± 1,6 p = 0,012
EDE-Q eating concerns 1,7 ± 1,9 2,4 ± 1,8 2,9 ± 1,9 2,7 ± 1,8 2,6 ± 2,0 NS
EDE-Q restraint 1,3 ± 1,2 2,2 ± 1,4 2,7 ± 1,6 2,6 ± 1,5 2,6 ± 1,5 p = 0,021
EDE-Q shape concern 2,2 ± 2,2 3,2 ± 1,8 4,1 ± 1,8 4,0 ± 1,9 3,9 ± 1,8 p = 0,002
EDE-Q weight concern 1,8 ± 1,8 2,6 ± 1,7 3,4 ± 1,9 3,3 ± 1,8 3,2 ± 2,0 p = 0,011
MADRS-S 13 ± 11 16 ± 10 21 ± 11 17 ± 10 20 ± 12 p = 0,035
Diagnoses (AN/BN/EDNOS) 7/0/4 12/1/47 9/3/88 4/3/72 1/2/22 p < 0,001
(64/0/36 %) (20/2/78 %) (9/3/88 %) (5/4/91 %) (4/8/88 %)
Pulse rate 58 ± 9 61 ± 8 63 ± 7 62 ± 7 63 ± 8 NS
Systolic blood pressure 99 ± 8 105 ± 9 106 ± 10 108 ± 11 110 ± 10 p = 0,012
Plasma potassium (mmol/L) 4,3 ± 0,2 4,2 ± 0,3 4,2 ± 0,2 4,2 ± 0,3 4,3 ± 0,3 NS
Plasma phosphate (mmol/L) 1,18 ± 0,18 1,19 ± 0,17 1,19 ± 0,15 1,19 ± 0,15 1,21 ± 0,11 NS
Serum free triodothyronine (pmol/L) 3,5 ± 1,9 4,2 ± 1,3 4,2 ± 1,2 4,0 ± 1,2 4,0 ± 0,9 NS
Serum insulin-like growth factor 1 (μg/L) 227 ± 136 275 ± 116 308 ± 125 286 ± 132 310 ± 115 NS
Serum luteinizing hormone (IU/L) 0,43 ± 0,47 0,67 ± 0,74 0,89 ± 1,25 1,04 ± 1,53 0,86 ± 0,75 NS
Patients are grouped in one SDS wide classes according to the BMI SDS at their highest weight before the onset of the eating disorder. Class 1 represents
premorbid BMI SDS
<−1,000, class 2 BMI SDS −1,000 - -0,001, class 3 BMI SDS 0–0,999, class 4 BMI SDS 1,000-1,999 and class 5 BMI SDS >1,999. Values are means ± SD. Statistical
analyses are by one-sided ANOVA and Chi-square test for continuous and categorical variables, respectively
Reference values for laboratory parameters: Plasma potassium 3,7-4,8 mmol//L, plasma phosphate 0,94–1,63 mmol/L, serum free triiodothyronine 3,9–7,7 pmol/L,
serum insulin-like growth factor 1 115–510 μg/L for age 12–15 years and 247–482 μg/L for age 16–20 years, serum luteinizing hormone >1 IU/L throughout the
menstrual cycle but highly variable
BMI SDS BMI standard deviation score, AN anorexia nervosa, BN bulimia nervosa and subthreshold bulimia nervosa, EDNOS eating disorders not otherwise
specified of restrictive subtype, EDE-Q eating disorders examination-questionnaire youth version; MADRS-S Montgomery-Åsberg depression rating scale-self report
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interventions and hospitalization [25]. The present data
indicate that the severity of these signs depend on not
only the low weight/BMI but also on the magnitude and
speed of weight loss. This forms a parallel with observa-
tions of prolongation of the QTc interval, a risk indicator
for cardiac arrhythmia, which is related to both low BMI
and to the rate of weight loss [26]. The importance of
the (rate of) weight change, and not only weight/BMI in
absolute terms, for the medical status is further under-
scored by the laboratory findings, which confirm previous
observations [27, 28] of the impact of ongoing weight loss
on the endocrinological profile. This profile is heteroge-
neous [29] and some girls may be amenorrhoic even at an
average weight [30]. Altogether, both the magnitude and
rate of weight loss contributes to medical instability and
cardiac risk [31, 32]. This emphasizes the need to carefully
assess the weight history at presentation of an ED and not
only register a point measure of weight.
The EDE-Q scores do not indicate that the girls in
the higher premorbid BMI SDS classes, who presented
with a higher BMI, had less eating disturbed cognitions
compared to those with an average premorbid BMI.
Compensatory behaviours were as prevalent as in the
leaner premorbid weight classes and their greater
weight loss suggests an even more restrictive eating.
Just because they present with a near average weight
they cannot be regarded as having a less severe ED.
They may indeed be more entrenched in ED behav-
iours due to a greater and in some cases more rapid
weight loss. This view is supported by the the observa-
tion in young adult women with AN that both low
BMI and high weight suppression is related to ED psy-
chopathology [14].
It is a novel observation that there is an increase in
BMI SDS from before puberty up to a top measurement
obtained post menarche in the higher premorbid BMI
SDS classes. There is no difference in age/gynaecological
age to explain this difference. It is likely that a high BMI
confers some degree of body dissatisfaction. In combin-
ation, the high BMI and dissatisfaction with body shape
and weight drives attempts to diet [33]. Even by the use
of extreme weight control measures the desired weight
loss is not achieved. Instead there is a further long-term
weight gain, which could maintain dieting behaviours
Table 2 Relationship between selected clinical and laboratory parameters and BMI SDS, total weight loss and rate of weight loss at
assessment of 268 postmenarcheal adolescent girls presenting with an eating disorder
Dependent variable Independent variables Beta R2 p
Pulse frequency BMI SDS 0,326 0,188 <0,001
Weight loss −0,199 0,070 <0,001
Final rate of weight loss −0,189 0,027 p = 0,003
Systolic blood pressure BMI SDS 0,311 0,152 <0,001
Weight loss - - -
Final rate of weight loss −0,249 0,056 <0,001
Plasma potassium BMI SDS - - -
Weight loss - - -
Final rate of weight loss - - -
Plasma phosphate BMI SDS - - -
Weight loss −0,141 0,020 p = 0,030
Final rate of weight loss - - -
Serum free triodothyronine BMI SDS 0,191 0,033 <0,001
Weight loss −0,347 0,267 <0,001
Final rate of weight loss −0,315 0,107 <0,001
Serum insulin-like growth factor 1 BMI SDS 0,260 0,073 <0,001
Weight loss −0,245 0,048 <0,001
Final rate of weight loss −0,333 0,275 <0,001
Serum luteinizing hormone BMI SDS 0,210 0,086 p = 0,003
Weight loss - - -
Final rate of weight loss −0,227 0,040 p = 0,001
The dependent variables were entered against BMI SDS, weight loss and the rate of weight loss immediately preceding assessment in a linear stepwise
regression analysis
BMI SDS BMI standard deviation score
Swenne BMC Psychiatry  (2016) 16:81 Page 5 of 7
and confer an increased risk of developing an ED [2, 3].
This suggests that ED cognitions and extreme weight
control behaviours may have been present in the highest
premorbid BMI SDS class even before the time point re-
ported as the onset of the ED.
Girls in the lowest premorbid BMI SDS class were
very lean at presentation. This strengthens the concept
of a relationship between premorbid BMI and BMI at
presentation [10], especially so since the present data is
based on documented measurements of weight and stat-
ure. These girls are constitutionally lean; their growth
charts show that they have grown along low weight tra-
jectories but have nevertheless achieved a pubertal
growth spurt and reached menarche. This indicates that
they are not always as medically compromised as their
low BMI would suggest. In support of this is the obser-
vation that several are not amenorrhoic and that vital
and laboratory parameters at presentation differ only lit-
tle compared to the less emaciated girls in the higher
premorbid BMI SDS classes. These very lean girls had
unexpectedly low EDE-Q scores. It was, however, evi-
dent that some of them had a feeding/eating disorder
with problematic eating behaviours but a less intensive
drive for thinness or fear of weight gain. They would be
diagnosed with EDNOS and score low on the EDE-Q
despite a weight which would qualify for AN. Further-
more, scrutinizing the case records of the leanest pre-
morbid BMI SDS class showed that there were several
patients with a mismatch between the low EDE-Q scores
and the description of ED cognitions/behaviours at the
initial interviews. It therefore appears that in some cases
denial or minimization of ED cognitions contribute to
low EDE-Q scores in this group.
The strength of the present study is foremost the avail-
ability of objective measurements of premorbid weight
in a sizable and unselected sample of adolescents with
ED. Moreover, the availability of care and absence of
doctor’s delay does not confound the analyses by adding
to the duration of disease and magnitude of weight loss.
There is a short-coming in the use of EDE-Q rather than
the EDE interview. Although there is agreement between
the two instruments [34] the EDE-Q may generate distor-
tion due to minimization or denial as indicated above.
Conclusion
In community samples of adolescents (subthreshold) bu-
limia nervosa is the ED usually associated with overweight
[35]. The present investigation clearly demonstrates that
restrictive ED may well be present among overweight ado-
lescents. This may be overlooked when overweight adoles-
cents are complimented on successful attempts to diet
and reinforced by approving comments from family and
peers. Indeed, the onset of weight loss may not necessarily
be the onset of the ED. It is nevertheless important to
consider the possibility of an ED when overweight adoles-
cents lose weight rapidly. When assessing an ED in such
adolescents a careful history of weight change and the
development of ED cognitions is necessary in order
not to underestimate the medical and psychological
severity of disease.
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